FindTrial
Sign In

Correlation of hormone levels and delirium after transnasal endoscopic pituitary tumor resection: a retrospective case study

Hormone levels effects on delirium after transnasal endoscopic pituitary tumor resection: a retrospective case study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100053607
Enrollment
Unknown
Registered
2021-11-25
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pituitary tumor

Interventions

Delirium group:None
Non-delirium group:None

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged >= 18 years, and gender is not limited; 2.Pituitary adenoma was confirmed by preoperative MRI, endocrinology and pathology, and endoscopic pituitary resection was performed; 3.GCS score >= 10 at admission; 4.Stay in ICU > 24 hours.

Exclusion criteria

Exclusion criteria: 1.Senile dementia; 2.Patients with immune diseases need to take hormone drugs for a long time; 3.Cases of nasal cavity and sinus infection; 4.Patients with unstable vital signs and hemodynamics after surgery; 5.Previous craniotomy history.

Design outcomes

Primary

MeasureTime frame
Postoperative pain classification;Delirium score;Basic admission information;Survey data;Analgesic drug use and therapeutic effect;Hormone drug use condition;Conditions of prognosis;—

Countries

China

Contacts

Public ContactTan Binbin

The First Affiliated Hospital of Army Medical University

27463547@qq.com+86 15086887071

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026